A NONEXCHANGEABLE APOLIPOPROTEIN-E PEPTIDE THAT MEDIATES BINDING TO THE LOW-DENSITY-LIPOPROTEIN RECEPTOR

被引:0
|
作者
MIMS, MP
DARNULE, AT
TOVAR, RW
POWNALL, HJ
SPARROW, DA
SPARROW, JT
VIA, DP
SMITH, LC
机构
[1] BAYLOR COLL MED, DEPT MED, HOUSTON, TX 77030 USA
[2] BAYLOR COLL MED, DEPT BIOCHEM, HOUSTON, TX 77030 USA
[3] BAYLOR COLL MED, DEPT PHYSIOL, HOUSTON, TX 77030 USA
关键词
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
ApoE is a 34-kDa apoprotein that mediates lipoprotein binding to the low density lipoprotein (LDL) receptor and to the LDL receptor-related protein. Receptor binding is mediated by a highly basic, alpha-helical sequence of similar to 15 amino acids that interacts with cysteine-rich repeat regions of the receptor. To determine the relationship between the receptor binding and lipid associating properties of apoE, we have synthesized a series of apoE peptides containing all (residues 129-169) or part (residues 139-169, 144-169, and 148-169) of the receptor-binding domain. The lipophilicity of these peptides was increased by modification of their N termini by acylation with either palmitic acid (C-16-apoE peptide) or the N,N-distearyl derivative of glycine (diC(18)-Gly-apoE peptide). The unmodified peptides demonstrated low affinity for lipid surfaces (K-d > 10(-5) M) and moderate alpha-helicity in the presence of lipid (40%) and had no effect on LDL uptake by fibroblasts. N-Palmitoyl peptides had increased affinity for lipid (K-d similar to 10(-6) M) and increased alpha-helicity (55%) in the presence of lipid. The addition of the C-16-apoE-(129-169)-peptide to I-125-LDL enhanced its uptake and degradation by fibroblasts 8-10-fold; however, <50% of the degradation was mediated by the LDL receptor. By contrast, the diC(18)-Gly-apoE-(129-169)-peptide was essentially nonexchangeable (K-d less than or equal to 10(-9) M) and highly helical (78%) in the presence of lipid. The addition of the diC(18)-Gly-apoE-(129-169)-peptide to I-125-LDL enhanced the specific uptake and degradation of LDL by both LDL receptor mediated and non-LDL receptor-mediated mechanisms. Uptake and degradation of methylated LDL containing diC(18)-Gly-apoE-(129-169) revealed that the lipoprotein-bound peptide is the active agent. In agreement with this finding a mutant diC(18)-Gly-apoE peptide (Arg(142) --> Gln) was much less effective than the wild-type peptide in potentiating binding, uptake, and degradation of I-125-LDL. Complexes of diC(18)-Gly-apoE-(129-169), apoA-I, and In summary, the receptor binding properties of apoE depend on its association with phospholipid; transfer of peptide fragments of the receptor-binding domain of apoE from the aqueous phase to a lipid surface converts them from a random coil to an alpha-helical conformation that is recognized by the LDL receptor, Moreover, since the N,N-distearylglycyl peptide is nonexchangeable, the data indicate that it can be used to probe the structural requirements for ligand binding and the processing of apoE-containing lipoproteins. 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine containing four to six copies of the peptide/particle displayed an affinity for the LDL receptor similar to that of apoE-L-alpha-dimyristoylphosphatidyl-choline discs containing four copies of apoE.
引用
收藏
页码:20539 / 20547
页数:9
相关论文
共 50 条
  • [21] EFFECT OF APOLIPOPROTEIN-E AND APOLIPOPROTEIN-A-IV PHENOTYPES ON THE LOW-DENSITY-LIPOPROTEIN RESPONSE TO HMG COA REDUCTASE INHIBITOR THERAPY
    ORDOVAS, JM
    LOPEZMIRANDA, J
    PEREZJIMENEZ, F
    RODRIGUEZ, C
    PARK, JS
    COLE, TG
    SCHAEFER, EJ
    CIRCULATION, 1994, 90 (04) : 666 - 666
  • [22] APOLIPOPROTEIN-E AND LIPOPROTEIN-LIPASE ACCELERATE THE BINDING OF TRIGLYCERIDE-RICH LIPOPROTEINS TO THE VERY-LOW-DENSITY LIPOPROTEIN RECEPTOR
    TAKAHASHI, S
    SUZUKI, J
    OIDA, K
    MIYABO, S
    YAMAMOTO, T
    NAKAI, T
    CIRCULATION, 1994, 90 (04) : 2 - 2
  • [23] A CHANGE IN APOLIPOPROTEIN-B EXPRESSION IS REQUIRED FOR THE BINDING OF APOLIPOPROTEIN-E TO VERY LOW-DENSITY LIPOPROTEIN
    ISHIKAWA, Y
    FIELDING, CJ
    FIELDING, PE
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1988, 263 (06) : 2744 - 2749
  • [24] APOLIPOPROTEIN-E UPTAKE AND DEGRADATION VIA CHLOROQUINE-SENSITIVE PATHWAY IN CULTIVATED MONKEY CELLS OVEREXPRESSING LOW-DENSITY-LIPOPROTEIN RECEPTOR
    JENSEN, TG
    ROSES, AD
    JORGENSEN, AL
    NEUROSCIENCE LETTERS, 1994, 180 (02) : 193 - 196
  • [25] IDENTIFICATION OF THE REGION OF APOLIPOPROTEIN-E RESPONSIBLE FOR LIPOPROTEIN RECEPTOR-BINDING
    INNERARITY, TL
    FRIEDLANDER, EJ
    RALL, SC
    WEISGRABER, KH
    MAHLEY, RW
    ARTERIOSCLEROSIS, 1982, 2 (05): : A433 - A433
  • [26] THE RECEPTOR-BINDING DOMAIN OF HUMAN APOLIPOPROTEIN-E - BINDING OF APOLIPOPROTEIN-E FRAGMENTS
    INNERARITY, TL
    FRIEDLANDER, EJ
    RALL, SC
    WEISGRABER, KH
    MAHLEY, RW
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1983, 258 (20) : 2341 - 2347
  • [27] THE BINDING OF VERY-LOW-DENSITY LIPOPROTEIN REMNANTS TO THE LOW-DENSITY-LIPOPROTEIN RECEPTOR IN FAMILIAL DEFECTIVE APOLIPOPROTEIN-B-100
    MAHER, VMG
    GALLAGHER, JJ
    MYANT, NB
    ATHEROSCLEROSIS, 1993, 102 (01) : 51 - 61
  • [28] Effect of arginine 172 on the binding of apolipoprotein E to the low density lipoprotein receptor
    Morrow, JA
    Arnold, KS
    Dong, J
    Balestra, ME
    Innerarity, TL
    Weisgraber, KH
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (04) : 2576 - 2580
  • [29] New insight into the low density lipoprotein receptor binding domain of apolipoprotein E
    Zaiou, M
    Arnold, KS
    Newhouse, YM
    Innerarity, TL
    Weisgraber, KH
    Phillips, MC
    Lund-Katz, S
    CIRCULATION, 1998, 98 (17) : 306 - 306
  • [30] INVOLVEMENT OF THE MACROPHAGE LOW-DENSITY-LIPOPROTEIN RECEPTOR-BINDING DOMAINS IN THE UPTAKE OF OXIDIZED LOW-DENSITY-LIPOPROTEIN
    KEIDAR, S
    BROOK, GJ
    ROSENBLAT, M
    FUHRMAN, B
    DANKNER, G
    AVIRAM, M
    ARTERIOSCLEROSIS AND THROMBOSIS, 1992, 12 (04): : 484 - 493